Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy

O'Brien V . Virus and apoptosis. J Gen Virol 1998; 66: 6939–6945.

Teodoro JG, Branton PE . Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5. J Virol 1997; 71: 3620–3627.

Teodoro JG, Branton PE . Regulation of apoptosis by viral gene products. J Virol 1997; 71: 1739–1746.

Tschopp J, Thome M, Hofmann K, Meinl E . The fight of viruses against apoptosis. Curr Opin Genet Dev 1998; 8: 82–87.

Nishiyama Y, Murata T . Anti-apoptotic protein kinase of herpes simplex virus. Trends Microbiol 2002; 10: 105–107.

Murata T, Goshima F, Daikoku T, Takakuwa H, Nishiyama Y . Expression of herpes simplex virus type 2 US3 affects the Cdc42/Rac pathway and attenuates c-Jun N-terminal kinase activation. Genes Cells 2000; 5: 1017–1027.

Leopardi R, Van Sant C, Roizman B . The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. Proc Natl Acad Sci USA 1997; 94: 7891–7896.

Munger J, Roizman B . The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins. Proc Natl Acad Sci USA 2001; 98: 10410–10415.

Nishiyama Y, Yamada Y, Kurachi R, Daikoku T . Construction of a US3 lacZ insertion mutant of herpes simplex virus type 2 and characterization of its phenotype in vitro and in vivo. Virology 1992; 190: 256–268.

Asano S, Honda T, Goshima F . US3 protein kinase of herpes simplex virus type 2 plays a role in protecting corneal epithelial cells from apoptosis in infected mice. J Gen Virol 1999; 80: 51–56.

Aubert M, Blaho JA . The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells. J Virol 1999; 73: 2803–2813.

Galvan V, Roizman B . Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc Natl Acad Sci USA 1998; 95: 3931–3936.

Koyama AH, Adachi H . Induction of apoptosis by herpes simplex virus type 1. J Gen Virol 1997; 78: 2909–2912.

Jerome KR, Tait JF, Koelle DM, Corey L . Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. J Virol 1998; 72: 436–441.

Galvan V, Bradimarti R, Roizman B . Herpes simplex virus 1 blocks caspase-3-independent and caspase-dependent pathways to cell death. J Virol 1999; 73: 3219–3226.

Leopardi R, Roizman B . The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia. Proc Natl Acad Sci USA 1996; 93: 9583–9587.

Jerome KR, Fox R, Chen Z, Sears AE, Lee H, Corey L . Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J Virol 1999; 73: 8950–8957.

Sawada T, Ho JJL, Chung YS . Stimulation of cellular motility by factor(s) released by SW1990 pancreatic cancer cells. Gastroenterology 1993; 104: A334.

Aoki K, Yoshida T, Matsumoto N . Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene. Hum Gene Ther 1997; 8: 1105–1113.

Hosono J, Narita T, Kimura N, Sato M, Nakashio T, Kasai Y . Involvement of adhesion molecules in metastasis of SW1990, human pancreatic cancer cells. J Surg Oncol 1998; 67: 77–84.

Rice SA, Lam V, Knipe DM . The acidic amino-terminal region of herpes simplex virus type 1 alpha protein ICP27 is required for an essential lytic function. J Virol 1993; 67: 1778–1787.

Carroll NM, Chiocca EA, Takahashi K, Tanabe KK . Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus. Ann Surg 1996; 224: 329–330.

Asano S, Honda T, Goshima F, Watanabe D, Miyake Y, Sugiura Y . US3 protein kinase of herpes simplex virus type 2 plays a role in protecting corneal epithelial cells from apoptosis in infected mice. J Gen Virol 1999; 80: 51–56.

Koyama AH, Akari H, Adachi A . Induction of apoptosis in Hep-2 cells by infection with herpes simplex virus type 2. Arch Virol 1998; 143: 2435–2441.

Antoni BA, Sabbatini P, Rabson AB, White E . Inhibition of apoptosis in human immunodeficiency virus-infected cells enhances virus production and facilitates persistent infection. J Virol 1995; 69: 2384–2392.

Chinnaiyan AM, Woffendin C, Dixit VM, Nabel GJ . The inhibition of pro-apoptotic ICE-like proteases enhances HIV replication. Nat Med 1997; 3: 333–337.

Sandstrom PA, Roberts B, Folks TM, Buttke TM . HIV gene expression enhances T cell susceptibility to hydrogen peroxide-induced apoptosis. AIDS Res Hum Retroviruses 1993; 9: 1107–1113.

Clem RJ, Fechheimer M, Miller LK . Protein prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 1991; 29: 1388–1390.

Brun A, Rivas C, Esteban M, Escribano JM, Alonso C . African swine fever virus gene A179L, a viral homologue of bcl-2, protects cells from programmed cell death. Virology 1996; 225: 227–230.

Afonso CL, Neilan JG, Kutish GF, Rock DL . An African swine fever virus Bc1-2 homolog, 5-HL, suppresses apoptotic cell death. J Virol 1996; 70: 4858–4863.

Gooding LR . Virus proteins that counteract host immune defenses. Cell 1992; 71: 5–7 Review.

Sauthoff H, Heitner S, Rom WN, Hay JG . Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector. Hum Gene Ther 2000; 11: 379–388.

Boulakia CA, Chen G, Ng FW, Teodoro JG, Branton PE, Nicholson DW . Bcl-2 and adenovirus E1B 19kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly (ADP-ribose) polymerase. Oncogene 1996; 12: 529–535.

Rao L, Perez D, White E . Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol 1996; 135: 1441–1455.

Hu MC, Hsu MT . Adenovirus E1B 19K protein is required for efficient DNA replication in U937 cells. Virology 1997; 227: 295–304.

Chiou SK, White E . Inhibition of ICE-like proteases inhibits apoptosis and increases virus production during adenovirus infection. Virology 1998; 244: 108–118.

Worgall S, Wolff G, Falck-Pedersen E, Crystal RG . Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther 1997; 8: 37–44.

Yeung SN, Tufaro F . Replicating herpes simplex virus vectors for cancer gene therapy. Expert Opin Pharmacother 2000; 1: 623–631.

Varghese S, Rabkin SD . Oncolytic herpes simplex virus vectors for cancer virotherapy. Cancer Gene Ther 2002; 9: 967–978 Review.

Nakao A, Kimata H, Imai T, Kikumori T, Teshigahara O, Nagasaka T . Injection of herpes simplex virus HF10 in recurrent breast cancer. Ann Oncol 2004; 15: 988–989.

Takakuwa H, Goshima F, Nozawa N, Yoshikawa T, Kimata H, Nakao A . Oncolytic viral therapy using a spontaneously generated herpes simplex virus type 1 variant for disseminated peritoneal tumor in immunocompetent mice. Arch Virol 2003; 148: 813–825.